Women's Hospital School Of Medicine Zhejiang University

This study tests two immunotherapy drugs (iparomlimab and tuvonralimab) in 30 women with a specific type of endometrial cancer that is mismatch repair deficient. The goal is to see if the drugs can make the cancer disappear or shrink enough to avoid surgery. Participants will rec…

This study tests whether adding the drug ivonescimab to standard chemotherapy before the usual chemoradiation can help people with high-risk, locally advanced cervical cancer. About 42 participants will receive two cycles of the combination, then standard treatment. The goal is t…